Vascular Closure Devices Market
Vascular Closure Devices: The Unique Technology for Faster, Safer, And Effective Closure Of Artery! Find Out More with FMI’s New Report
Vascular Closure Devices Market by Product, Application, End User & Region - Forecast 2022 - 2032
Vascular Closure Devices Market Outlook (2022-2032)
[250 Pages Report] The global vascular closure devices market size reached US$ 1.3 Bn in 2021 and is expected to enjoy a valuation of US$ 1.4 Bn by the end of 2022. Furthermore, amid rising usage of vascular closure devices for immediate sealing of an artery after medical procedures, the overall demand in the market is set to grow at a CAGR of 5.4% during the forecast period, totalling a valuation of ~US$ 2.4 Bn by 2032.
By product, with around 80.0% share in 2021, the active approximators segment will continue to dominate the global vascular closure devices market during the forecast period.
|
Attribute |
Key Statistics |
|
Vascular Closure Devices Market Base Value (2021) |
US$ 1.3 Bn |
|
Estimated Market Size (2022) |
US$ 1.4 Bn |
|
Projected Market Size (2032) |
US$ 2.4 Bn |
|
Value-based CAGR (2022-2032) |
5.4% |
|
Market Share of Top 5 Countries |
48.7% |
The development of minimally invasive techniques in many surgical specialties is still ongoing, and vascular surgery is no exception. A variety of medical specialties, including vascular surgery, interventional cardiology, and interventional radiology, use angiograms as one of the most widely used diagnostic procedures today.
For these procedures, manual compression has frequently been used at the access site to achieve haemostasis. Although manual compression is still the method of choice in this situation, a variety of vascular closure devices have been created to assist the surgeon in achieving that goal.
Vascular closure devices are innovative devices designed to provide immediate sealing of the small puncture made in an artery after an angiogram. These devices provide an alternative to manual compression and thus help in fast sealing of puncture, thereby eliminating the need for prolonged compression.
Vascular closure devices are being increasingly used in patients undergoing catheterization via the femoral route. They have the potential to reduce the time to haemostasis, facilitate early patient mobilization, minimize the risk of complication, and improve patient satisfaction.
Factors such as rising prevalence of cardiovascular diseases, increasing number of cardiac procedures being performed across the world, favourable reimbursement policies, and growing focus towards effective blood loss management in patients during surgical procedures are expected to boost growth of the vascular closure devices market during the forecast period.
Similarly, continuous new product launches and approvals along with rapid expansion of healthcare industry across emerging economies will bode well for the market growth over the next ten years.
The vascular closure devices market held approximately 6.4% value share of the overall ~US$ 20.79 Bn global interventional cardiology devices market in 2021.
Let us know your requirement to get
100% FREE customization
Sales Analysis of Vascular Closure Devices from 2012 to 2021 Vs Market Outlook for 2022 to 2032
The global sales of vascular closure devices grew at a CAGR of 4.8% during the historical period of 2012 and 2021. However, with growing prevalence of cardiovascular diseases, rise in minimally invasive procedures, and growing adoption of advanced medical technologies, the overall vascular closure device sales are projected to rise at 5.4% CAGR between 2022 and 2032.
Vascular surgery has dramatically changed in the last few decades, moving away from traditional open surgery and towards an extensive array of percutaneous endovascular interventions. One of the most popular ways to gain vascular access for both therapeutic and diagnostic vascular operations is through the common femoral artery.
Over 7 million percutaneous procedures are carried out annually throughout the world (Journal of Vascular Surgery 2018). While radial access is becoming more and more popular, the common femoral artery is still used for the majority of them. The "gold standard" for attaining haemostasis has continued to be manual compression, but it can be labour and resource-intensive, requiring extended bed rest after completion, and is uncomfortable for both the patient and the caregiver.
By using a device that is fastened over the top of the skin, external haemostatic devices deliver mechanical compression to the arteriotomy site. Several commercially available devices have received FDA approval, and these include QuicKlamp, CompressAR, StrongArm, and FemoStop.
The development of vascular closure devices has significantly changed vascular surgery and increased interest in percutaneous vascular procedures. Following both diagnostic and therapeutic percutaneous vascular interventions, vascular closure devices have demonstrated a notable increase in haemostasis and ambulation. Additionally, the patients' comfort, contentment, and quality of life have significantly improved through these interventions.
With a high prevalence of cardiovascular diseases due to changing lifestyles, improper diet, and age-related cardiac ailments, demand for vascular closure devices is expected to grow at a steady pace during the next ten years.
What are the Key Trends Driving the Vascular Closure Devices Market?
“Gradual Shift from Manual Compression to Vascular Closure Devices Augmenting Market Growth”
Although manual compression remains the best method for achieving haemostasis at catheterization vascular access site arteriotomies, there is a resurgence of interest in technologies that can expedite vascular closure in the current cost-conscious healthcare environment.
While the use of these devices might result in higher procedural expenses, users of these technologies claim that attaining haemostasis more quickly results in significant savings further on.
Vascular closure devices offer various potential advantages including a decrease in post-procedural nursing care time, a decrease in bleeding problems, increased patient throughput, improved patient satisfaction, and quicker patient ambulation. Hospitals with same-day percutaneous coronary intervention (PCI) programmes benefit from getting patients up and moving around more quickly.
Additionally, because of the increased need for minimally invasive interventions, which is gaining ground swiftly; these factors give the manufacturers the opportunity to introduce new product lines. The recent FDA clearance of Vascette® HP (Haemostatic Pad) for radial and femoral vascular closures during cardiac catheterizations in August 2022, demonstrates innovative introduction of innovations with plant-derived haemostatic foam to enable rapid haemostasis without direct compression over the arterial puncture site.
The market for vascular closure devices is expected to experience substantial growth over the forecasted years owing to the aforementioned factors.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors Restraining the Growth of Vascular Closure Devices Market?
The fact that many vascular closure devices leave behind metal hardware that permanently fuses to the vessel wall is a critical challenge for these devices. It is contended that these elements may result in the formation of scar tissue or provide difficulties for future vascular access.
The device limitations also include the potential for device malfunction and failure, a slight risk of infection, the likelihood of limb ischemia brought on by artery narrowing, localised thrombosis, high learning period, and device costs. The possibility of infection with vascular closure devices is low, but it should be taken into account.
A number of variables, such as device features and performance, patient characteristics, which include obesity, can affect results of vascular closure devices. Other factors include anticoagulation, the type of intervention carried out, operator experience, and anatomic challenges.
These factors pose limitations towards the growth of the global vascular closure devices market.
Country-wise Insights
Will the U.S. Continue to Retain its Dominance in North America Vascular Closure Devices Market?
“A Sharp Rise in Cardiovascular Diseases Bolstering Demand in the U.S.”
As per FMI, the U.S. dominated North American vascular closure devices market with a total market share of about 80.0% in 2021, and is expected to continue to experience the same growth throughout the forecast period. Growth in the U.S. vascular closure devices market is driven by rising prevalence of obesity and cardiovascular diseases among the American population, increase in the number of cardiac procedures being performed, rising adoption of advanced medical technologies, and continuous new product launches by key players.
Over the years, there has been a sharp rise in the mortality rate of cardiovascular disease, which has prompted people to opt for early cardiac interventions. According to the Centers for Disease Control and Prevention (CDC), around 697,000 people died from heart diseases in the United States during 2020. Furthermore, it is estimated that one person dies every 34 seconds in the country from cardiovascular disease. This will continue to generate demand for vascular closure devices in the U.S. during the forecast period.
Moreover, a rapidly growing U.S. healthcare system further supports the growth of the vascular closure devices market within the country.
How is Vascular Closure Devices Market Faring in Germany?
“Increasing Incidence of Heart Diseases Driving Market in Germany”
Germany held a market share of about 4.6% in the global vascular closure devices market in 2021 and it is poised to exhibit a steady growth rate during the assessment period owing to the surge in the number of heart diseases, flourishing medical tourism, and high adoption rate of advanced medical technologies and procedures.
According to the Borgen Project (2017), Germany has one of the highest rates of heart disease in the world, with the eighth-highest incidence of deaths attributable to the condition. In Germany, heart disease claims the lives of over 310 persons each year out of every 100,000 people. This factor is expected to fuel the demand for vascular closure devices within the country.
What Makes China a Highly Lucrative Market for Vascular Closure Devices?
“Rapid Expansion of Healthcare Industry Propelling Sales in China Market”
China held approximately 7.1% share in the global vascular closure devices market in 2021 and is likely to remain one of the most lucrative markets across East Asia during the forecast period. The rapid development of healthcare infrastructure in the country, as well as the total automation of manufacturing and production of medical equipment have presented lucrative opportunities for the growth of the vascular closure devices market in China.
Similarly, rapidly growing geriatric population, easy availability of products at lower costs, and favourable government support are expected to expand the vascular closure devices market size in the country during the next ten years.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Which is the Most Widely Used Product in Vascular Closure Devices Market?
“Active Approximators Remain the Highly Sought-After Product in the Market”
As per FMI, the active approximators segment held a share of around 80.0% in the global vascular closure devices market in 2021 and is expected to continue its dominance even during the forecast period. This can be attributed to the rising adoption of active approximators by end users for sealing an artery after angiogram owing to their increased safety and lower risk of complications, and improved patient comfort.
Active approximators present a high growth opportunity for the global vascular closure devices market owing to their high efficiency rate during the closure of an access site, without direct contact of the arterial wall.
Which Application Contributes Most to the Vascular Closure Devices Market?
“Cardiac Interventions Will Remain the Most Lucrative Application Area for Vascular Closure Devices”
Cardiac interventions segment held the highest market share value of about 45.0% in the global vascular closure devices market in 2021 and it is expected to generate the highest revenues during the forecast period. Growing prevalence of cardiovascular diseases, expansion of diagnostic tools and services, as well as the growth of minimally invasive techniques, are promoting the adoption of vascular closure devices during cardiac interventions.
Cardiac interventions are necessary to influence the overall quality of health care for patients. Use of vascular closure devices post procedures like an angiogram, has aided with positive patient outcomes, thus promoting traction towards the overall market growth during the forecast years.
Which is the Leading End User of Vascular Closure Devices?
“Majority of Vascular Closure Device Sales Remain Concentrated in Hospitals”
Hospitals segment held a revenue share of about 48.0% in 2021 within the global market and is likely to contribute most during the forecast period, owing to the high procedural rates in diagnostic and interventional cardiology.
Furthermore, with rapid expansion of hospitals across the globe and presence of infrastructure and services supporting comprehensive care for cardiology patients, this segment will continue to lead the overall vascular closure devices market in the coming years.
Competitive Landscape
The global vascular closure devices market is highly competitive in nature due to the presence of several local, regional, and established global players. In order to capitalize, focusing on adopting strategies such as new product launches and approvals, investments in research and development, mergers, partnerships, collaborations, and acquisitions.
Some of the recent development in vascular closure devices market include:
- The Pulsar®-18 T3 peripheral self-expanding stent device from BIOTRONIK was given FDA approval in July 2022 for a superior implantation technique for endovascular interventions.
- Cordis (a Cardinal Health subsidiary), introduced the MYNX CONTROLTM Vascular Closure Device in the United States in November 2018. To increase safety, predictability, and ease of use when sealing 5-7F femoral arterial access sites, MYNX CONTROLTM VCD combines active extravascular sealing and resorbability features with a next-gen delivery technology.
Report Scope as per Vascular Closure Devices Industry Analysis
|
Attribute |
Details |
|
Estimated Market Size (2022) |
US$ 1.4 Bn |
|
Projected Market Size (2032) |
US$ 2.4 Bn |
|
Anticipated Growth Rate (2022-2032) |
5.4% |
|
Forecast Period |
2012-2021 |
|
Historical Data Available for |
2022-2032 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
|
Key Countries Covered |
U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa |
|
Key Market Segments Covered |
Product, Application, End User, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Key Market Segments Covered in Vascular Closure Devices Industry Research
By Product:
- Passive Approximators
- Collagen Plugs
- Sealant or Gel-based Devices
- Compression-assist Devices
- Active Approximators
- Suture-based Devices
- Clip-based Devices
- External Haemostatic Devices
By Application:
- Cardiac Interventions
- Cerebrovascular Interventions
- Peripheral Vascular Interventions
- Others
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global vascular closure devices market size is expected to reach US$ 1.4 Bn in 2022.
Sales of vascular closure devices market are set to witness a growth rate of 5.4% CAGR during the forecast period, reaching a total market valuation of around US$ 2.4 Bn by 2032.
The global vascular closure devices market increased at 4.8% CAGR from 2012 to 2021.
The U.S., China, Germany, Japan, and the U.K are driving the demand for vascular closure devices, collectively holding around 48.7% market share.
The U.S. accounts for around 80.0% share of the North American vascular closure devices market in 2021.
Abbott, BIOTRONIK, and Cardinal Health, are the top three manufacturers of vascular closure devices.
China held a share of about 7.1% in the global vascular closure devices market in 2021.
Japan held a share of about 29.7% within the East Asia vascular closure devices market in 2021.
Germany holds a share value of around 23.0% within the Europe vascular closure devices market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Promotional Strategies, By Key Manufacturers
4.2. Key Regulations
4.3. Value Chain Analysis
4.4. Regulatory Impositions
4.5. Reimbursement Scenario
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Interventional Cardiology Devices Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Growing Geriatric Age Group Population
5.2.2. New Product Launch Activities
5.2.3. High Prevalence of Cardiovascular Diseases
5.2.4. Cost of Vascular Closure Devices
5.2.5. Rising Volumes of Surgical Procedures
5.2.6. Technological Innovations
5.2.7. Advancement in Minimally Invasive Techniques
5.2.8. Device Regulations
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By End User
6.1.4. By Country
6.2. 2021 Market Scenario
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012–2021 and Forecast, 2022–2032
8.1. Historical Market Value (US$ Mn) Analysis, 2012-2021
8.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Volume (Units) Analysis 2012–2021 and Forecast, 2022–2032
9.1. Historical Market Volume (Units) Analysis, 2012-2021
9.2. Current and Future Market Volume (Units) Projections, 2022–2032
9.2.1. Y-o-Y Growth Trend Analysis
10. Global Market Analysis 2012-2021 and Forecast 2022–2032, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2012 - 2021
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022 - 2032
10.3.1. Passive Approximators
10.3.1.1. Collagen Plugs
10.3.1.2. Sealant or Gel-based Devices
10.3.1.3. Compression-assist Devices
10.3.2. Active Approximators
10.3.2.1. Suture-based Devices
10.3.2.2. Clip-based Devices
10.3.3. External Hemostatic Devices
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2012-2021 and Forecast 2022–2032, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Application, 2012 - 2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022 - 2032
11.3.1. Cardiac Interventions
11.3.2. Cerebrovascular Interventions
11.3.3. Peripheral Vascular Interventions
11.3.4. Others
11.4. Market Attractiveness Analysis By Application
12. Global Market Analysis 2012-2021 and Forecast 2022–2032, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2012 - 2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2032
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Cardiac Catheterization Laboratories
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2012-2021 and Forecast 2022–2032, By Region
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2012–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012–2021
14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022–2032
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. U.S. Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast By Market Taxonomy
14.8.1.2.1. By Country
14.8.1.2.2. By Product
14.8.1.2.3. By Application
14.8.1.2.4. By End User
14.8.2. Canada Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast By Market Taxonomy
14.8.2.2.1. By Country
14.8.2.2.2. By Product
14.8.2.2.3. By Application
14.8.2.2.4. By End User
15. Latin America Market Analysis 2012–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012–2021
15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022–2032
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.1.4.1. By Country
15.3.1.4.2. By Product
15.3.1.4.3. By Application
15.3.1.4.4. By End User
15.4. Market Attractiveness Analysis
15.4.1.1.1. By Country
15.4.1.1.2. By Product
15.4.1.1.3. By Application
15.4.1.1.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Mexico Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast By Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. Brazil Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast By Market Taxonomy
15.8.2.2.1. By Country
15.8.2.2.2. By Product
15.8.2.2.3. By Application
15.8.2.2.4. By End User
15.8.3. Argentina Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast By Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application
15.8.3.2.3. By End User
16. Europe Market Analysis 2012–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012–2021
16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Nordic Countries & Russia
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Germany Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast By Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Italy Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast By Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. By End User
16.8.3. France Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast By Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application
16.8.3.2.3. By End User
16.8.4. U.K. Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast By Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Application
16.8.4.2.3. By End User
16.8.5. Spain Market Analysis
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast By Market Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By Application
16.8.5.2.3. By End User
16.8.6. BENELUX Market Analysis
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast By Market Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By Application
16.8.6.2.3. By End User
16.8.7. Russia Market Analysis
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast By Market Taxonomy
16.8.7.2.1. By Product
16.8.7.2.2. By Application
16.8.7.2.3. By End User
17. East Asia Market Analysis 2012–2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012–2021
17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. China Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast By Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.1.2.3. By End User
17.8.2. Japan Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast By Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.2.2.3. By End User
17.8.3. South Korea Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast By Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Application
17.8.3.2.3. By End User
18. South Asia Market Analysis 2012–2021 and Forecast 2022–2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012–2021
18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022–2032
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Malaysia
18.3.1.4. Thailand
18.3.1.5. Rest of South Asia
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. India Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast By Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. Indonesia Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast By Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application
18.8.2.2.3. By End User
18.8.3. Malaysia Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast By Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Application
18.8.3.2.3. By End User
18.8.4. Thailand Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast By Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Application
18.8.4.2.3. By End User
19. Oceania Market 2012-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012–2021
19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022–2032
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By End User
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
19.7. Country Level Analysis & Forecast
19.7.1. Australia Market Analysis
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast By Market Taxonomy
19.7.1.2.1. By Product
19.7.1.2.2. By Application
19.7.1.2.3. By End User
19.7.2. New Zealand Market Analysis
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast By Market Taxonomy
19.7.2.2.1. By Product
19.7.2.2.2. By Application
19.7.2.2.3. By End User
20. Middle East and Africa (MEA) Market Analysis 2012–2021 and Forecast 2022–2032
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012–2021
20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022–2032
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. North Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Application
20.4.4. By End User
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country Level Analysis & Forecast
20.8.1. GCC Countries Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast By Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Application
20.8.1.2.3. By End User
20.8.2. Turkey Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast By Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Application
20.8.2.2.3. By End User
20.8.3. South Africa Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast By Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By Application
20.8.3.2.3. By End User
20.8.4. North Africa Market Analysis
20.8.4.1. Introduction
20.8.4.2. Market Analysis and Forecast By Market Taxonomy
20.8.4.2.1. By Product
20.8.4.2.2. By Application
20.8.4.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis By Tier of Companies
21.2. Market Concentration
21.3. Market Share Analysis (%) of Top Players
21.4. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Abbott
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Key Financials
22.3.1.5. SWOT Analysis
22.3.1.6. Strategic Overview
22.3.2. BIOTRONIK
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Key Financials
22.3.2.5. SWOT Analysis
22.3.2.6. Strategic Overview
22.3.3. Cardinal Health
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Key Financials
22.3.3.5. SWOT Analysis
22.3.3.6. Strategic Overview
22.3.4. Cardiva Medical, Inc.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Key Financials
22.3.4.5. SWOT Analysis
22.3.4.6. Strategic Overview
22.3.5. Medtronic plc
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Key Financials
22.3.5.5. SWOT Analysis
22.3.5.6. Strategic Overview
22.3.6. Merit Medical Systems, Inc.
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Key Financials
22.3.6.5. SWOT Analysis
22.3.6.6. Strategic Overview
22.3.7. Teleflex Incorporated
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Key Financials
22.3.7.5. SWOT Analysis
22.3.7.6. Strategic Overview
22.3.8. Terumo Medical Corporation
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Key Financials
22.3.8.5. SWOT Analysis
22.3.8.6. Strategic Overview
22.3.9. Tricol Medical
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. Key Financials
22.3.9.5. SWOT Analysis
22.3.9.6. Strategic Overview
22.3.10. Z-Medica, LLC
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. Key Financials
22.3.10.5. SWOT Analysis
22.3.10.6. Strategic Overview
22.3.11. KOAG LLC
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Sales Footprint
22.3.11.4. Key Financials
22.3.11.5. SWOT Analysis
22.3.11.6. Strategic Overview
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product
Table 02: Global Market Volume (Units) Analysis and Forecast 2012–2032, by Product
Table 03: Global Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application
Table 04: Global Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User
Table 05: Global Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Region
Table 06: North America Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country
Table 07: North America Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product
Table 08: North America Market Volume (Units) Analysis and Forecast 2012–2032, by Product
Table 09: North America Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application
Table 10: North America Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User
Table 11: Latin America Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country
Table 12: Latin America Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product
Table 13: Latin America Market Volume (Units) Analysis and Forecast 2012–2032, by Product
Table 14: Latin America Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application
Table 15: Latin America Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User
Table 16: Europe Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country
Table 17: Europe Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product
Table 18: Europe Market Volume (Units) Analysis and Forecast 2012–2032, by Product
Table 19: Europe Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application
Table 20: Europe Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User
Table 21: South Asia Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country
Table 22: South Asia Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product
Table 23: South Asia Market Volume (Units) Analysis and Forecast 2012–2032, by Product
Table 24: South Asia Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application
Table 25: South Asia Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User
Table 26: East Asia Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country
Table 27: East Asia Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product
Table 28: East Asia Market Volume (Units) Analysis and Forecast 2012–2032, by Product
Table 29: East Asia Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application
Table 30: East Asia Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User
Table 31: Oceania Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country
Table 32: Oceania Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product
Table 33: Oceania Market Volume (Units) Analysis and Forecast 2012–2032, by Product
Table 34: Oceania Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application
Table 35: Oceania Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User
Table 36: MEA Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country
Table 37: MEA Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product
Table 38: MEA Market Volume (Units) Analysis and Forecast 2012–2032, by Product
Table 39: MEA Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application
Table 40: MEA Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Volume (Units), 2012 – 2021
Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022–2032
Figure 03: Vascular Closure Devices, Pricing Analysis per unit (US$), in 2022
Figure 04: Vascular Closure Devices, Pricing Forecast per unit (US$), in 2032
Figure 05: Global Market Value Analysis (US$ Mn), 2012 – 2021
Figure 06: Global Market Value Forecast (US$ Mn), 2022-2032
Figure 07: Global Market Absolute $ Opportunity, 2021 - 2031
Figure 08: Global Market Share Analysis (%), by Product, 2022-2032
Figure 09: Global Market Y-o-Y Analysis (%), by Product, 2022-2032
Figure 10: Global Market Attractiveness Analysis by Product, 2022-2032
Figure 11: Global Market Share Analysis (%), by Application, 2022-2032
Figure 12: Global Market Y-o-Y Analysis (%), by Application, 2022-2032
Figure 13: Global Market Attractiveness Analysis by Application, 2022-2032
Figure 14: Global Market Share Analysis (%), by End User, 2022-2032
Figure 15: Global Market Y-o-Y Analysis (%), by End User, 2022-2032
Figure 16: Global Market Attractiveness Analysis by End User, 2022-2032
Figure 17: Global Market Share Analysis (%), by Region, 2022-2032
Figure 18: Global Market Y-o-Y Analysis (%), by Region, 2022-2032
Figure 19: Global Market Attractiveness Analysis by Region, 2022-2032
Figure 20: North America Market Value Share, by Product, 2022 (E)
Figure 21: North America Market Value Share, by Application, 2022 (E)
Figure 22: North America Market Value Share, by End User, 2022 (E)
Figure 23: North America Market Value Share, by Country, 2022 (E)
Figure 24: North America Market Value Analysis (US$ Mn), 2012 – 2021
Figure 25: North America Market Value Forecast (US$ Mn), 2022-2032
Figure 26: North America Market Attractiveness Analysis by Product, 2022-2032
Figure 27: North America Market Attractiveness Analysis, by Application 2022-2032
Figure 28: North America Market Attractiveness Analysis by End User, 2022-2032
Figure 29: North America Market Attractiveness Analysis by Country, 2022-2032
Figure 30: U.S. Market Share Analysis (%), by Product, 2022 & 2032
Figure 31: U.S. Market Share Analysis (%), by Application, 2022 & 2032
Figure 32: U.S. Market Share Analysis (%), by End User, 2022 & 2032
Figure 33: U.S. Market Value Analysis (US$ Mn), 2022 & 2032
Figure 34: Canada Market Share Analysis (%), by Product, 2022 & 2032
Figure 35: Canada Market Share Analysis (%), by Application, 2022 & 2032
Figure 36: Canada Market Share Analysis (%), by End User, 2022 & 2032
Figure 37: Canada Market Value Analysis (US$ Mn), 2022 & 2032
Figure 38: Latin America Market Value Share, by Product, 2022 (E)
Figure 39: Latin America Market Value Share, by Application, 2022 (E)
Figure 40: Latin America Market Value Share, by End User, 2022 (E)
Figure 41: Latin America Market Value Share, by Country, 2022 (E)
Figure 42: Latin America Market Value Analysis (US$ Mn), 2012 – 2021
Figure 43: Latin America Market Value Forecast (US$ Mn), 2022-2032
Figure 44: Latin America Market Attractiveness Analysis by Product, 2022-2032
Figure 45: Latin America Market Attractiveness Analysis by Application, 2022-2032
Figure 46: Latin America Market Attractiveness Analysis by End User, 2022-2032
Figure 47: Latin America Market Attractiveness Analysis by Country, 2022-2032
Figure 48: Brazil Market Share Analysis (%), by Product, 2022 & 2032
Figure 49: Brazil Market Share Analysis (%), by Application, 2022 & 2032
Figure 50: Brazil Market Share Analysis (%), by End User, 2022 & 2032
Figure 51: Brazil Market Value Analysis (US$ Mn), 2022 & 2032
Figure 52: Mexico Market Share Analysis (%), by Product, 2022 & 2032
Figure 53: Mexico Market Share Analysis (%), by Application, 2022 & 2032
Figure 54: Mexico Market Share Analysis (%), by End User, 2022 & 2032
Figure 55: Mexico Market Value Analysis (US$ Mn), 2022 & 2032
Figure 56: Argentina Market Share Analysis (%), by Product, 2022 & 2032
Figure 57: Argentina Market Share Analysis (%), by Application, 2022 & 2032
Figure 58: Argentina Market Share Analysis (%), by End User, 2022 & 2032
Figure 59: Argentina Market Value Analysis (US$ Mn), 2022 & 2032
Figure 60: Europe Market Value Share, by Product, 2022 (E)
Figure 61: Europe Market Value Share, by Application, 2022 (E)
Figure 62: Europe Market Value Share, by End User, 2022 (E)
Figure 63: Europe Market Value Share, by Country, 2022 (E)
Figure 64: Europe Market Value Analysis (US$ Mn), 2012 – 2021
Figure 65: Europe Market Value Forecast (US$ Mn), 2022-2032
Figure 66: Europe Market Attractiveness Analysis by Product, 2022-2032
Figure 67: Europe Market Attractiveness Analysis by Application, 2022-2032
Figure 68: Europe Market Attractiveness Analysis by End User, 2022-2032
Figure 69: Europe Market Attractiveness Analysis by Country, 2022-2032
Figure 70: Germany Market Share Analysis (%), by Product, 2022 & 2032
Figure 71: Germany Market Share Analysis (%), by Application, 2022 & 2032
Figure 72: Germany Market Share Analysis (%), by End User, 2022 & 2032
Figure 73: Germany Market Value Analysis (US$ Mn), 2022 & 2032
Figure 74: Italy Market Share Analysis (%), by Product, 2022 & 2032
Figure 75: Italy Market Share Analysis (%), by Application, 2022 & 2032
Figure 76: Italy Market Share Analysis (%), by End User, 2022 & 2032
Figure 77: Italy Market Value Analysis (US$ Mn), 2022 & 2032
Figure 78: France Market Share Analysis (%), by Product, 2022 & 2032
Figure 79: France Market Share Analysis (%), by Application, 2022 & 2032
Figure 80: France Market Share Analysis (%), by End User, 2022 & 2032
Figure 81: France Market Value Analysis (US$ Mn), 2022 & 2032
Figure 82: UK Market Share Analysis (%), by Product, 2022 & 2032
Figure 83: UK Market Share Analysis (%), by Application, 2022 & 2032
Figure 84: UK Market Share Analysis (%), by End User, 2022 & 2032
Figure 85: UK Market Value Analysis (US$ Mn), 2022 & 2032
Figure 86: Spain Market Share Analysis (%), by Product, 2022 & 2032
Figure 87: Spain Market Share Analysis (%), by Application, 2022 & 2032
Figure 88: Spain Market Share Analysis (%), by End User, 2022 & 2032
Figure 89: Spain Market Value Analysis (US$ Mn), 2022 & 2032
Figure 90: BENELUX Market Share Analysis (%), by Product, 2022 & 2032
Figure 91: BENELUX Market Share Analysis (%), by Application, 2022 & 2032
Figure 92: BENELUX Market Share Analysis (%), by End User, 2022 & 2032
Figure 93: BENELUX Market Value Analysis (US$ Mn), 2022 & 2032
Figure 94: Russia Market Share Analysis (%), by Product, 2022 & 2032
Figure 95: Russia Market Share Analysis (%), by Application, 2022 & 2032
Figure 96: Russia Market Share Analysis (%), by End User, 2022 & 2032
Figure 97: Russia Market Value Analysis (US$ Mn), 2022 & 2032
Figure 98: South Asia Market Value Share, by Product, 2022 (E)
Figure 99: South Asia Market Value Share, by Application, 2022 (E)
Figure 100: South Asia Market Value Share, by End User, 2022 (E)
Figure 101: South Asia Market Value Share, by Country, 2022 (E)
Figure 102: South Asia Market Value Analysis (US$ Mn), 2012 – 2021
Figure 103: South Asia Market Value Forecast (US$ Mn), 2022-2032
Figure 104: South Asia Market Attractiveness Analysis by Product, 2022-2032
Figure 105: South Asia Market Attractiveness Analysis by Application, 2022-2032
Figure 106: South Asia Market Attractiveness Analysis by End User, 2022-2032
Figure 107: South Asia Market Attractiveness Analysis by Country, 2022-2032
Figure 108: India Market Share Analysis (%), by Product, 2022 & 2032
Figure 109: India Market Share Analysis (%), by Application, 2022 & 2032
Figure 110: India Market Share Analysis (%), by End User, 2022 & 2032
Figure 111: India Market Value Analysis (US$ Mn), 2022 & 2032
Figure 112: Indonesia Market Share Analysis (%), by Product, 2022 & 2032
Figure 113: Indonesia Market Share Analysis (%), by Application, 2022 & 2032
Figure 114: Indonesia Market Share Analysis (%), by End User, 2022 & 2032
Figure 115: Indonesia Market Value Analysis (US$ Mn), 2022 & 2032
Figure 116: Thailand Market Share Analysis (%), by Product, 2022 & 2032
Figure 117: Thailand Market Share Analysis (%), by Application, 2022 & 2032
Figure 118: Thailand Market Share Analysis (%), by End User, 2022 & 2032
Figure 119: Thailand Market Value Analysis (US$ Mn), 2022 & 2032
Figure 120: Malaysia Market Share Analysis (%), by Product, 2022 & 2032
Figure 121: Malaysia Market Share Analysis (%), by Application, 2022 & 2032
Figure 122: Malaysia Market Share Analysis (%), by End User, 2022 & 2032
Figure 123: Malaysia Market Value Analysis (US$ Mn), 2022 & 2032
Figure 124: East Asia Market Value Share, by Product, 2022 (E)
Figure 125: East Asia Market Value Share, by Application, 2022 (E)
Figure 126: East Asia Market Value Share, by End User, 2022 (E)
Figure 127: East Asia Market Value Share, by Country, 2022 (E)
Figure 128: East Asia Market Value Analysis (US$ Mn), 2012 – 2021
Figure 129: East Asia Market Value Forecast (US$ Mn), 2022-2032
Figure 130: East Asia Market Attractiveness Analysis by Product, 2022-2032
Figure 131: East Asia Market Attractiveness Analysis by Application, 2022-2032
Figure 132: East Asia Market Attractiveness Analysis by End User, 2022-2032
Figure 133: East Asia Market Attractiveness Analysis by Country, 2022-2032
Figure 134: China Market Share Analysis (%), by Product, 2022 & 2032
Figure 135: China Market Share Analysis (%), by Application, 2022 & 2032
Figure 136: China Market Share Analysis (%), by End User, 2022 & 2032
Figure 137: China Market Value Analysis (US$ Mn), 2022 & 2032
Figure 138: Japan Market Share Analysis (%), by Product, 2022 & 2032
Figure 139: Japan Market Share Analysis (%), by Application, 2022 & 2032
Figure 140: Japan Market Share Analysis (%), by End User, 2022 & 2032
Figure 141: Japan Market Value Analysis (US$ Mn), 2022 & 2032
Figure 142: South Korea Market Share Analysis (%), by Product, 2022 & 2032
Figure 143: South Korea Market Share Analysis (%), by Application, 2022 & 2032
Figure 144: South Korea Market Share Analysis (%), by End User, 2022 & 2032
Figure 145: South Korea Market Value Analysis (US$ Mn), 2022 & 2032
Figure 146: Oceania Market Value Share, by Product, 2022 (E)
Figure 147: Oceania Market Value Share, by Application, 2022 (E)
Figure 148: Oceania Market Value Share, by End User, 2022 (E)
Figure 149: Oceania Market Value Share, by Country, 2022 (E)
Figure 150: Oceania Market Value Analysis (US$ Mn), 2012 – 2021
Figure 151: Oceania Market Value Forecast (US$ Mn), 2022-2032
Figure 152: Oceania Market Attractiveness Analysis by Product, 2022-2032
Figure 153: Oceania Market Attractiveness Analysis by Application, 2022-2032
Figure 154: Oceania Market Attractiveness Analysis by End User, 2022-2032
Figure 155: Oceania Market Attractiveness Analysis by Country, 2022-2032
Figure 156: Australia Market Share Analysis (%), by Product, 2022 & 2032
Figure 157: Australia Market Share Analysis (%), by Application, 2022 & 2032
Figure 158: Australia Market Share Analysis (%), by End User, 2022 & 2032
Figure 159: Australia Market Value Analysis (US$ Mn), 2022 & 2032
Figure 160: New Zealand Market Share Analysis (%), by Product, 2022 & 2032
Figure 161: New Zealand Market Share Analysis (%), by Application, 2022 & 2032
Figure 162: New Zealand Market Share Analysis (%), by End User, 2022 & 2032
Figure 163: New Zealand Market Value Analysis (US$ Mn), 2022 & 2032
Figure 164: MEA Market Value Share, by Product, 2022 (E)
Figure 165: MEA Market Value Share, by Application, 2022 (E)
Figure 166: MEA Market Value Share, by End User, 2022 (E)
Figure 167: MEA Market Value Share, by Country, 2022 (E)
Figure 168: MEA Market Value Analysis (US$ Mn), 2012 – 2021
Figure 169: MEA Market Value Forecast (US$ Mn), 2022-2032
Figure 170: MEA Market Attractiveness Analysis by Product, 2022-2032
Figure 171: MEA Market Attractiveness Analysis by Application, 2022-2032
Figure 172: MEA Market Attractiveness Analysis by End User, 2022-2032
Figure 173: MEA Market Attractiveness Analysis by Country, 2022-2032
Figure 174: GCC Countries Market Share Analysis (%), by Product, 2022 & 2032
Figure 175: GCC Countries Market Share Analysis (%), by Application, 2022 & 2032
Figure 176: GCC Countries Market Share Analysis (%), by End User, 2022 & 2032
Figure 177: GCC Countries Market Value Analysis (US$ Mn), 2022 & 2032
Figure 178: Turkey Market Share Analysis (%), by Product, 2022 & 2032
Figure 179: Turkey Market Share Analysis (%), by Application, 2022 & 2032
Figure 180: Turkey Market Share Analysis (%), by End User, 2022 & 2032
Figure 181: Turkey Market Value Analysis (US$ Mn), 2022 & 2032
Figure 182: South Africa Market Share Analysis (%), by Product, 2022 & 2032
Figure 183: South Africa Market Share Analysis (%), by Application, 2022 & 2032
Figure 184: South Africa Market Share Analysis (%), by End User, 2022 & 2032
Figure 185: South Africa Market Value Analysis (US$ Mn), 2022 & 2032
Figure 186: North Africa Market Share Analysis (%), by Product, 2022 & 2032
Figure 187: North Africa Market Share Analysis (%), by Application, 2022 & 2032
Figure 188: North Africa Market Share Analysis (%), by End User, 2022 & 2032
Figure 189: North Africa Market Value Analysis (US$ Mn), 2022 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
